Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2014

Open Access 01-12-2014 | Study protocol

Mechanisms, predictors and clinical impact of early neurological deterioration: the protocol of the Trondheim early neurological deterioration study

Authors: Bernt Harald Helleberg, Hanne Ellekjær, Gitta Rohweder, Bent Indredavik

Published in: BMC Neurology | Issue 1/2014

Login to get access

Abstract

Background

10-40% of patients with acute ischemic stroke (AIS) suffer an early neurological deterioration (END), which may influence their long term prognosis. Multiple definitions of END exist, even in recently published papers. In the search for causes, various biochemical, clinical, and imaging markers have been found to be associated to END after AIS in some but not in other studies.
The primary aim of this study is to assess the contribution of END to functional level at 3 months post stroke measured by modified Rankin Scale (mRS). Secondary aims are to identify factors and mechanisms associated with END and to define the prevalence, degree and timing of END in relation to stroke onset, and to compare Scandinavian Stroke Scale (SSS) and National Institute of Health Stroke Scale (NIHSS) based END-definitions.
We hypothesized that END detected by changes in NIHSS and SSS (according to previously published criteria) at a threshold of 2 points indicate worsened prognosis, and that SSS is not inferior to NIHSS in predicting such a change. We further hypothesized that clinical deterioration has several causes, including impaired physiological homeostasis, vascular pathology, local effects and reactions secondary to the ischemic lesion, along with biochemical disturbances.

Methods

Single-centre prospective observational study.
Participants: Previously at home-dwelling patients admitted to our stroke unit within 24 hours after ictus of AIS are included into the study, and followed for 3 months. They are managed according to current procedures and national guidelines. A total of 368 patients are included by the end of the enrolment period (December 31st 2013), and the material will be opened for analysis by June 30th 2014.
Frequent neurological assessments, continuous monitoring, and repeated imaging and blood samples are performed in all patients in order to test the hypotheses.

Discussion

Strengths and weaknesses of our approach, along with reasons for the methods chosen in this study are discussed.
Literature
1.
2.
Millikan CH, Siekert RG: Studies in cerebrovascular disease. I. The syndrome of intermittent insufficiency of the basilar arterial system. Proc Staff Meet Mayo Clin. 1955, 30 (4): 61-68.PubMed
3.
Millikan CH, Siekert RG: Studies in cerebrovascular disease. IV. The syndrome of intermittent insufficiency of the carotid arterial system. Proc Staff Meet Mayo Clin. 1955, 30 (9): 186-191.PubMed
4.
Siegler JE, Martin-Schild S: Early Neurological Deterioration (END) after stroke: the END depends on the definition. Int J Stroke. 2011, 6 (3): 211-212. 10.1111/j.1747-4949.2011.00596.x.CrossRefPubMed
5.
Jones HJ, Millikan CH: Temporal profile (clinical course) of acute carotid system cerebral infarction. Stroke. 1976, 7 (1): 64-71. 10.1161/01.STR.7.1.64.CrossRefPubMed
6.
Jorgensen HS, Nakayama H, Raaschou HO, Vive-Larsen J, Stoier M, Olsen TS: Outcome and time course of recovery in stroke. Part I: Outcome. The Copenhagen Stroke Study. Arch Phys Med Rehabil. 1995, 76 (5): 399-405. 10.1016/S0003-9993(95)80567-2.CrossRefPubMed
7.
Dàvalos A, Cendra E, Teruel J, Martinez M, Genis D: Deteriorating ischemic stroke: risk factors and prognosis. Neurology. 1990, 40: 1865-1869. 10.1212/WNL.40.12.1865.CrossRefPubMed
8.
Dàvalos A, Toni D, Iweins FL, Lesaffre E, Bastianello S, Castillo J: Neurological deterioiation in acute ischemic stroke: potential predictors and associated factors in the European Cooperative Acute Stroke Study (ECASS) I. Stroke. 1999, 30: 2631-2636. 10.1161/01.STR.30.12.2631.CrossRefPubMed
9.
Britton M, Roden A: Progression of stroke after arrival at hospital. Stroke. 1985, 16 (4): 629-632. 10.1161/01.STR.16.4.629.CrossRefPubMed
10.
Birchel P, Ellul J, Barer D: Progressing stroke: towards an internationally agreed definition. Cerebrovasc Dis. 2004, 17: 242-252. 10.1159/000076161.CrossRef
11.
Weimar C, Mieck T, Buchthal J, Ehrenfeld CE, Schmid E, Diener HC: Neurologic worsening during the acute phase of ischemic stroke. Arch Neurol. 2005, 62 (3): 393-397. 10.1001/archneur.62.3.393.CrossRefPubMed
12.
Barber M, Stott DJ, Langhorne P: An internationally agreed definition of progressing stroke. Cerebrovasc Dis. 2004, 18 (3): 255-256. 10.1159/000080112.CrossRefPubMed
13.
Irino T, Watanabe M, Nishide M, Gotoh M, Tsuchiya T: Angiographical analysis of acute cerebral infarction followed by “cascade”-like deterioration of minor neurological deficits. What is progressing stroke?. Stroke. 1983, 14 (3): 363-368. 10.1161/01.STR.14.3.363.CrossRefPubMed
14.
Thanvi B, Treadwell S, Robinson T: Early neurological deterioration in acute ischaemic stroke: predictors, mechanisms and management. Postgrad Med J. 2008, 84 (994): 412-417. 10.1136/pgmj.2007.066118.CrossRefPubMed
15.
Alvarez FJ, Segura T, Castellanos M, Leira R, Blanco M, Castillo J, Davalos A, Serena J: Cerebral hemodynamic reserve and early neurologic deterioration in acute ischemic stroke. J Cereb Blood Flow Metab. 2004, 24 (11): 1267-1271.PubMed
16.
Baizabal-Carvallo JF, Alonso-Juarez M, Samson Y: Clinical Deterioration following Middle Cerebral Artery Hemodynamic Changes after Intravenous Thrombolysis for Acute Ischemic Stroke. J Stroke Cerebrovasc Dis. 2013, 23 (2): 254-258. 10.1016/j.jstrokecerebrovasdis.2013.01.015.CrossRefPubMed
17.
DeGraba TJ, Hallenbeck JM, Pettigrew KD, Dutka AJ, Kelly BJ: Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials. Stroke. 1999, 30 (6): 1208-1212. 10.1161/01.STR.30.6.1208.CrossRefPubMed
18.
Cuadrado-Godia E, Jimena S, Ois A, Rodriguez-Campello A, Giralt-Steinhauer E, Soriano-Tarraga C, Jimenez-Conde J, Martinez-Rodriguez JE, Capellades J, Roquer J: Factors associated with early outcome in patients with large-vessel carotid strokes. J Neurol Neurosurg Psychiatry. 2013, 84 (3): 305-309. 10.1136/jnnp-2012-303638.CrossRefPubMed
19.
Davalos A, Castillo J, Marrugat J, Fernandez-Real JM, Armengou A, Cacabelos P, Rama R: Body iron stores and early neurologic deterioration in acute cerebral infarction. Neurology. 2000, 54 (8): 1568-1574. 10.1212/WNL.54.8.1568.CrossRefPubMed
20.
Castillo J, Davalos A, Naveiro J, Noya M: Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke. 1996, 27 (6): 1060-1065. 10.1161/01.STR.27.6.1060.CrossRefPubMed
21.
Vila N, Castillo J, Davalos A, Chamorro A: Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke. 2000, 31 (10): 2325-2329. 10.1161/01.STR.31.10.2325.CrossRefPubMed
22.
Castillo J, Davalos A, Noya M: Progression of ischaemic stroke and excitotoxic aminoacids. Lancet. 1997, 349 (9045): 79-83. 10.1016/S0140-6736(96)04453-4.CrossRefPubMed
23.
Castillo J, Rama R, Davalos A: Nitric oxide-related brain damage in acute ischemic stroke. Stroke. 2000, 31 (4): 852-857. 10.1161/01.STR.31.4.852.CrossRefPubMed
24.
Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ: Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression. Stroke. 2004, 35 (6): 1421-1425. 10.1161/01.STR.0000126890.63512.41.CrossRefPubMed
25.
Barber M, Wright F, Stott DJ, Langhorne P: Predictors of early neurological deterioration after ischaemic stroke: a case-control study. Gerontology. 2004, 50 (2): 102-109. 10.1159/000075561.CrossRefPubMed
26.
Vila N, Castillo J, Davalos A, Esteve A, Planas AM, Chamorro A: Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke. 2003, 34 (3): 671-675. 10.1161/01.STR.0000057976.53301.69.CrossRefPubMed
27.
Choi KH, Park MS, Kim JT, Chang J, Nam TS, Choi SM, Lee SH, Kim BC, Kim MK, Cho KH: Serum triglyceride level is an important predictor of early prognosis in patients with acute ischemic stroke. J Neurol Sci. 2012, 319 (1-2): 111-116. 10.1016/j.jns.2012.04.018.CrossRefPubMed
28.
Alexandrov AV, Sharma VK, Lao AY, Tsivgoulis G, Malkoff MD, Alexandrov AW: Reversed Robin Hood syndrome in acute ischemic stroke patients. Stroke. 2007, 38 (11): 3045-3048. 10.1161/STROKEAHA.107.482810.CrossRefPubMed
29.
Steinke W: Lacunar stroke is the major cause of progressive motor deficits. Stroke. 2002, 33 (6): 1510-1516. 10.1161/01.STR.0000016326.78014.FE.CrossRefPubMed
30.
Tei H, Uchiyama S, Ohara K, Kobayashi M, Uchiyama Y, Fukuzawa M: Deteriorating ischemic stroke in 4 clinical categories classified by the oxfordshire community project. Stroke. 2000, 31: 2039-2044. 10.1161/01.STR.31.9.2049.CrossRef
31.
Alexandrov AV, Grotta JC: Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology. 2002, 59 (6): 862-867. 10.1212/WNL.59.6.862.CrossRefPubMed
32.
Bang OY, Kim GM, Chung CS, Kim SJ, Kim KH, Jeon P, Saver JL, Liebeskind DS, Lee KH: Differential pathophysiological mechanisms of stroke evolution between new lesions and lesion growth: perfusion-weighted imaging study. Cerebrovasc Dis. 2010, 29 (4): 328-335. 10.1159/000278928.CrossRefPubMed
33.
Caplan LR, Hennerici M: Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol. 1998, 55 (11): 1475-1482. 10.1001/archneur.55.11.1475.CrossRefPubMed
34.
Backhaus R, Boy S, Fuchs K, Ulrich B, Schuierer G, Schlachetzki F: Hyperperfusion syndrome after MCA embolectomy - a rare complication?. Am J Case Rep. 2013, 14: 513-517. 10.12659/AJCR.889672.CrossRefPubMedPubMedCentral
35.
Serena J, Rodriguez-Yanez M, Castellanos M: Deterioration in acute ischemic stroke as the target for neuroprotection. Cerebrovasc Dis. 2006, 21 Suppl 2: 80-88. 10.1159/000091707.CrossRefPubMed
36.
Govan L, Langhorne P, Weir CJ: Does the prevention of complications explain the survival benefit of organized inpatient (stroke unit) care? - Further analysis of a systematic review. Stroke. 2007, 38 (9): 2536-2540. 10.1161/STROKEAHA.106.478842.CrossRefPubMed
37.
Indredavik B, Rohweder G, Naalsund E, Lydersen S: Medical complications in a comprehensive stroke unit and an early supported discharge service. Stroke. 2008, 39 (2): 414-420. 10.1161/STROKEAHA.107.489294.CrossRefPubMed
38.
Goldfarb S, McCullough PA, McDermott J, Gay SB: Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. Mayo Clin Proc. 2009, 84 (2): 170-179. 10.4065/84.2.170.CrossRefPubMedPubMedCentral
39.
Indredavik B, Bakke F, Solberg R, Rokseth R, Haaheim LL, Holme I: Benefit of a stroke unit: a randomized controlled trial. Stroke. 1991, 22 (8): 1026-1031. 10.1161/01.STR.22.8.1026.CrossRefPubMed
40.
Fjaertoft H, Indredavik B, Lydersen S: Stroke unit care combined with early supported discharge: long-term follow-up of a randomized controlled trial. Stroke. 2003, 34 (11): 2687-2691. 10.1161/01.STR.0000095189.21659.4F.CrossRefPubMed
41.
Sundseth A, Thommessen B, Ronning OM: Outcome after mobilization within 24 hours of acute stroke: a randomized controlled trial. Stroke. 2012, 43 (9): 2389-2394. 10.1161/STROKEAHA.111.646687.CrossRefPubMed
42.
Indredavik B, Slordahl SA, Bakke F, Rokseth R, Haheim LL: Stroke unit treatment. Long-term effects. Stroke. 1997, 28 (10): 1861-1866. 10.1161/01.STR.28.10.1861.CrossRefPubMed
43.
Indredavik B, Bakke F, Slordahl SA, Rokseth R, Haheim LL: Stroke unit treatment. 10-year follow-up. Stroke. 1999, 30 (8): 1524-1527. 10.1161/01.STR.30.8.1524.CrossRefPubMed
44.
Fjaertoft H, Rohweder G, Indredavik B: Stroke unit care combined with early supported discharge improves 5-year outcome: a randomized controlled trial. Stroke. 2011, 42 (6): 1707-1711. 10.1161/STROKEAHA.110.601153.CrossRefPubMed
45.
46.
Robbins NM, Swanson RA: Opposing effects of glucose on stroke and reperfusion injury: acidosis, oxidative stress, and energy metabolism. Stroke. 2014, 45 (6): 1881-1886. 10.1161/STROKEAHA.114.004889.CrossRefPubMedPubMedCentral
47.
Kammersgaard LP, Jorgensen HS, Rungby JA, Reith J, Nakayama H, Weber UJ, Houth J, Olsen TS: Admission body temperature predicts long-term mortality after acute stroke: the Copenhagen Stroke Study. Stroke. 2002, 33 (7): 1759-1762. 10.1161/01.STR.0000019910.90280.F1.CrossRefPubMed
48.
Crosby RD, Kolotkin RL, Williams GR: Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol. 2003, 56 (5): 395-407. 10.1016/S0895-4356(03)00044-1.CrossRefPubMed
Metadata
Title
Mechanisms, predictors and clinical impact of early neurological deterioration: the protocol of the Trondheim early neurological deterioration study
Authors
Bernt Harald Helleberg
Hanne Ellekjær
Gitta Rohweder
Bent Indredavik
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2014
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-014-0201-4

Other articles of this Issue 1/2014

BMC Neurology 1/2014 Go to the issue

Research article

Predictors and long-term outcome of seizures in human immuno-deficiency virus (HIV)-negative cryptococcal meningitis

Case report

Sjögren’s syndrome and Neuromyelitis Optica spectrum disorders (NMOSD) - a case report and review of literature

Research article

Βeta-fibrinogen gene promoter A −455 allele associated with poor longterm survival among 55–71 years old Caucasian women in Finnish stroke cohort

Study protocol

Emergence and evolution of social self-management of Parkinson’s disease: study protocol for a 3-year prospective cohort study

Research article

Effects of minimally invasive procedures for evacuation of intracerebral hematoma in early stages on MMP-9 and BBB permeability in rabbits

Research article

Recurrent stroke risk is high after a single cerebrovascular event in patients with symptomatic 50-99% carotid stenosis: a cohort study